FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1204439001: Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4955600015 Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4955601016 Hydralazine and isosorbide dinitrate only product in oral dose form en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Is a Product containing only hydralazine and isosorbide dinitrate (medicinal product) true Inferred relationship Existential restriction modifier
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Is a Product containing hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Has active ingredient Hydralazine true Inferred relationship Existential restriction modifier 1
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Has active ingredient Isosorbide dinitrate true Inferred relationship Existential restriction modifier 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely hydralazine hydrochloride 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet (clinical drug) Is a True Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start